QUESTIONS_AND_ANSWERS_Studies_to_Enhance_FDA_Communications_Medical_Countermeasures.doc

QUESTIONS AND ANSWERS

SOLICITATION NUMBER # FDA-16-RFP-1160119

Studies to Enhance FDA Communications Addressing Medical Countermeasures Question 01 Has a contractor performed similar work to this for the government in the past?

If available, please provide the incumbent contract number.

Answer 01 No.

Question 02 If you are unable to provide a contract number, is it safe to assume this is a new requirement for the government?

Answer 02 Yes.

Question 03 Is there a prime target audience for the messages or is the target audience the general public?

Answer 03 The general public, including racially diverse underserved audiences.

Question 04 The RFP states that OCOMM has developed a “series of medical countermeasures-related risk communication messages and information that can be used in each of these public health emergencies with the general public.” In what format will these messages be provided to the contractor (e.g. draft posters, videos, infographics)?

Answer 04 Text

Question 05 Is there an incumbent contractor for these services, and, if so, are they eligible to submit a proposal?

Answer 05 No.

Question 06 Can you please describe the target audience for each the focus groups and online survey?

Answer 06 The general public, including racially diverse and underserved audiences.

Question 07 Can you please provide specs for the online survey (i.e., expected average survey length, number of open-ended questions, desired sample size, screening criteria, etc.)?

Answer 07 The company would need to propose this.

Question 08 (Page 6: 3.4.4d and 3.4.5) Will FDA confirm that the contractor is responsible for rewriting messages for FDA approval following completion of research?

Answer 08 Yes, contractor is responsible for revising the messages based on the findings from the focus groups and the survey, which would then be reviewed and approved by FDA.

Question 09 (Page 6: 3.4.4d and 3.4.5) Will FDA confirm that they will provide initial messages for testing and that the contractor will not be responsible for drafting these?

Answer 09 Yes, FDA will provide initial messages to be tested.

Question 10 (Page 22: 9.5 – Price Proposal) As part of this proposal, does FDA require any information in addition to completion of Table 2.1? If so, what information needs to be provided?

Answer 10 Please clarify question.

Question 11 Is there a page limit for the Technical Proposal or Relevant Past Performance?

Answer 11 30 pages.